Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Synergetic bitherapy in mice with xenografts of human prostate cancer using a methional mimic (METLICO) and an aldehyde dehydrogenase 3 inhibitor (MATE): systemic intraperitoneal (IP) and targeted intra-tumoral (IT) administration.

Hiltbrand E, Fournet G, Giliberto JP, Paret MJ, Chantepie J, Morel D, Goré J, Reichert U, Mehier H, Rochedix ME, Quash G.

Curr Med Chem. 2009;16(10):1184-91.

PMID:
19355878
2.

Aldehyde dehydrogenase inhibitors: alpha,beta-acetylenic N-substituted aminothiolesters are reversible growth inhibitors of normal epithelial but irreversible apoptogens for cancer epithelial cells from human prostate in culture.

Quash G, Fournet G, Courvoisier C, Martinez RM, Chantepie J, Paret MJ, Pharaboz J, Joly-Pharaboz MO, Goré J, André J, Reichert U.

Eur J Med Chem. 2008 May;43(5):906-16. Epub 2007 Jul 6.

PMID:
17692435
3.
4.

Strategies to improve the therapy of retained fetal membranes in dairy cows.

Drillich M, Mahlstedt M, Reichert U, Tenhagen BA, Heuwieser W.

J Dairy Sci. 2006 Feb;89(2):627-35.

5.

Ligation of RARgamma inhibits proliferation of phytohaemagglutinin-stimulated T-cells via down-regulating JAK3 protein levels.

Ludányi K, Nagy ZS, Alexa M, Reichert U, Michel S, Fésüs L, Szondy Z.

Immunol Lett. 2005 Apr 15;98(1):103-13. Epub 2004 Nov 24.

PMID:
15790515
6.

Retinoids induce Fas(CD95) ligand cell surface expression via RARgamma and nur77 in T cells.

Tóth B, Ludányi K, Kiss I, Reichert U, Michel S, Fésüs L, Szondy Z.

Eur J Immunol. 2004 Mar;34(3):827-836. doi: 10.1002/eji.200324760.

7.

Anaplerotic reactions in tumour proliferation and apoptosis.

Quash G, Fournet G, Reichert U.

Biochem Pharmacol. 2003 Aug 1;66(3):365-70. Review.

PMID:
12907234
8.

Identification and characterization of a cell cycle and apoptosis regulatory protein-1 as a novel mediator of apoptosis signaling by retinoid CD437.

Rishi AK, Zhang L, Boyanapalli M, Wali A, Mohammad RM, Yu Y, Fontana JA, Hatfield JS, Dawson MI, Majumdar AP, Reichert U.

J Biol Chem. 2003 Aug 29;278(35):33422-35. Epub 2003 Jun 18.

9.

Ligation of retinoic acid receptor alpha regulates negative selection of thymocytes by inhibiting both DNA binding of nur77 and synthesis of bim.

Szegezdi E, Kiss I, Simon A, Blaskó B, Reichert U, Michel S, Sándor M, Fésüs L, Szondy Z.

J Immunol. 2003 Apr 1;170(7):3577-84.

10.

Synthetic retinoid CD437 induces cell-dependent cycle arrest by differential regulation of cell cycle associated proteins.

Shyu RY, Lin DY, Reichert U, Jiang SY.

Anticancer Res. 2002 Sep-Oct;22(5):2757-64.

PMID:
12529993
11.

Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analog.

Zhang Y, Dawson MI, Mohammad R, Rishi AK, Farhana L, Feng KC, Leid M, Peterson V, Zhang XK, Edelstein M, Eilander D, Biggar S, Wall N, Reichert U, Fontana JA.

Blood. 2002 Oct 15;100(8):2917-25.

PMID:
12351403
12.
13.

Cyclin B and E2F-1 expression in prostate carcinoma cells treated with the novel retinoid CD437 are regulated by the ubiquitin-mediated pathway.

Farhana L, Dawson M, Rishi AK, Zhang Y, Van Buren E, Trivedi C, Reichert U, Fang G, Kirschner MW, Fontana JA.

Cancer Res. 2002 Jul 1;62(13):3842-9.

14.

Cell death in HIV pathogenesis and its modulation by retinoids.

Szondy Z, Tóth R, Szegezdi E, Reichert U, Ancian P, Fésüs L.

Ann N Y Acad Sci. 2001 Nov;946:95-107. Review.

PMID:
11762998
15.

Effects of retinoic acid receptor-selective agonists on human nasal epithelial cell differentiation.

Million K, Tournier F, Houcine O, Ancian P, Reichert U, Marano F.

Am J Respir Cell Mol Biol. 2001 Dec;25(6):744-50.

PMID:
11726401
16.

Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.

Kim MJ, Deplewski D, Ciletti N, Michel S, Reichert U, Rosenfield RL.

Mol Genet Metab. 2001 Nov;74(3):362-9.

PMID:
11708867
17.

Isolation of a recombinant formate dehydrogenase by pseudo-affinity expanded bed adsorption.

Reichert U, Knieps E, Slusarczyk H, Kula MR, Thömmes J.

J Biochem Biophys Methods. 2001 Oct 30;49(1-3):533-52.

PMID:
11694300
18.

Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor alpha and gamma and involve nur77 in T cells.

Tóth R, Szegezdi E, Reichert U, Bernardon JM, Michel S, Ancian P, Kis-Tóth K, Macsári Z, Fésüs L, Szondy Z.

Eur J Immunol. 2001 May;31(5):1382-91.

19.

Influence of imidazole replacement in different structural classes of histamine H(3)-receptor antagonists.

Meier G, Apelt J, Reichert U, Grassmann S, Ligneau X, Elz S, Leurquin F, Ganellin CR, Schwartz JC, Schunack W, Stark H.

Eur J Pharm Sci. 2001 Jun;13(3):249-59.

PMID:
11384847
20.

The effect of a novel irreversible inhibitor of aldehyde dehydrogenases 1 and 3 on tumour cell growth and death.

Canuto RA, Muzio G, Salvo RA, Maggiora M, Trombetta A, Chantepie J, Fournet G, Reichert U, Quash G.

Chem Biol Interact. 2001 Jan 30;130-132(1-3):209-18.

PMID:
11306045
21.

Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid.

Ponzanelli I, Giannì M, Giavazzi R, Garofalo A, Nicoletti I, Reichert U, Erba E, Rambaldi A, Terao M, Garattini E.

Blood. 2000 Apr 15;95(8):2672-82.

PMID:
10753850
22.

[Structure, function and potential therapeutic possibilities of NMDA receptors. 2. Therapy concepts and new receptor ligands].

Stark H, Reichert U, Grassmann S.

Pharm Unserer Zeit. 2000 Jul;29(4):228-36. Review. German. No abstract available.

PMID:
10969535
23.

13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors.

Tsukada M, Schröder M, Roos TC, Chandraratna RA, Reichert U, Merk HF, Orfanos CE, Zouboulis CC.

J Invest Dermatol. 2000 Aug;115(2):321-7.

24.

[Structure, function and potential therapeutic possibilites of NMDA receptors. 1. Architecture and modulation of receptors].

Stark H, Grassmann S, Reichert U.

Pharm Unserer Zeit. 2000 May;29(3):159-66. Review. German. No abstract available.

PMID:
10881600
25.

Differential effects of several retinoid receptor-selective ligands on squamous differentiation and apoptosis in airway epithelial cells.

Boisvieux-Ulrich E, Le Pechon-Vallée C, Million K, Baeza-Squiban A, Houcine O, Guennou C, Reichert U, Marano F.

Cell Tissue Res. 2000 Apr;300(1):67-81.

PMID:
10805076
26.

Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases.

Gianni M, Ponzanelli I, Mologni L, Reichert U, Rambaldi A, Terao M, Garattini E.

Cell Death Differ. 2000 May;7(5):447-60.

27.

Identification of a unique binding protein specific for a novel retinoid inducing cellular apoptosis.

Fontana JA, Dawson MI, Leid M, Rishi AK, Zhang Y, Hsu CA, Lu JS, Peterson VJ, Jong L, Hobbs P, Chao WR, Shroot B, Reichert U.

Int J Cancer. 2000 May 15;86(4):474-9.

28.

S-phase arrest and apoptosis induced in normal mammary epithelial cells by a novel retinoid.

Zhang Y, Rishi AK, Dawson MI, Tschang R, Farhana L, Boyanapalli M, Reichert U, Shroot B, Van Buren EC, Fontana JA.

Cancer Res. 2000 Apr 1;60(7):2025-32.

29.

Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure.

Arafa HM, Elmazar MM, Hamada FM, Reichert U, Shroot B, Nau H.

Arch Toxicol. 2000 Jan;73(10-11):547-56.

PMID:
10663386
30.

The role of specific retinoid receptors in sebocyte growth and differentiation in culture.

Kim MJ, Ciletti N, Michel S, Reichert U, Rosenfield RL.

J Invest Dermatol. 2000 Feb;114(2):349-53.

31.

Involvement of cyclin-dependent kinase activities in CD437-induced apoptosis.

Hsu SL, Yin SC, Liu MC, Reichert U, Ho WL.

Exp Cell Res. 1999 Nov 1;252(2):332-41.

PMID:
10527623
32.

Post-transcriptional regulation of the DNA damage-inducible gadd45 gene in human breast carcinoma cells exposed to a novel retinoid CD437.

Rishi AK, Sun RJ, Gao Y, Hsu CK, Gerald TM, Sheikh MS, Dawson MI, Reichert U, Shroot B, Fornace AJ Jr, Brewer G, Fontana JA.

Nucleic Acids Res. 1999 Aug 1;27(15):3111-9.

33.

The RARgamma selective agonist CD437 inhibits gastric cell growth through the mechanism of apoptosis.

Jiang SY, Lin DY, Shyu RY, Reichert U, Yeh MY.

Cancer Lett. 1999 Apr 1;137(2):217-25.

PMID:
10374844
34.

A thioester analogue of an amino acetylenic aldehyde is a suicide inhibitor of aldehyde dehydrogenase and an inducer of apoptosis in mouse lymphoid cells overexpressing the bcl2 gene.

Quash G, Fournet G, Raffin C, Chantepie J, Michal Y, Gore J, Reichert U.

Adv Exp Med Biol. 1999;463:97-106. No abstract available.

PMID:
10352674
35.

Retinoic acids regulate apoptosis of T lymphocytes through an interplay between RAR and RXR receptors.

Szondy Z, Reichert U, Fésüs L.

Cell Death Differ. 1998 Jan;5(1):4-10. Review.

36.

Activation of the p38 and JNK/SAPK mitogen-activated protein kinase pathways during apoptosis is mediated by a novel retinoid.

Zhang Y, Huang Y, Rishi AK, Sheikh MS, Shroot B, Reichert U, Dawson M, Poirer G, Fontana JA.

Exp Cell Res. 1999 Feb 25;247(1):233-40.

PMID:
10047465
37.

The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases.

Mologni L, Ponzanelli I, Bresciani F, Sardiello G, Bergamaschi D, Gianní M, Reichert U, Rambaldi A, Terao M, Garattini E.

Blood. 1999 Feb 1;93(3):1045-61.

PMID:
9920855
38.

Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.

Fontana JA, Sun RJ, Rishi AK, Dawson MI, Ordónez JV, Zhang Y, Tschang SH, Bhalla K, Han Z, Wyche J, Poirer G, Sheikh MS, Shroot B, Reichert U.

Oncol Res. 1998;10(6):313-24.

PMID:
9848102
39.

Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivo.

Langdon SP, Rabiasz GJ, Ritchie AA, Reichert U, Buchan P, Miller WR, Smyth JF.

Cancer Chemother Pharmacol. 1998;42(5):429-32.

PMID:
9771960
40.

Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha.

Szondy Z, Reichert U, Bernardon JM, Michel S, Tóth R, Karászi E, Fésüs L.

Biochem J. 1998 May 1;331 ( Pt 3):767-74.

41.
42.

Retinoic acid receptors alpha and gamma mediate the induction of "tissue" transglutaminase activity and apoptosis in human neuroblastoma cells.

Melino G, Draoui M, Bellincampi L, Bernassola F, Bernardini S, Piacentini M, Reichert U, Cohen P.

Exp Cell Res. 1997 Aug 25;235(1):55-61.

PMID:
9281352
43.

Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway.

Hsu CA, Rishi AK, Su-Li X, Gerald TM, Dawson MI, Schiffer C, Reichert U, Shroot B, Poirer GC, Fontana JA.

Blood. 1997 Jun 15;89(12):4470-9.

PMID:
9192771
44.

Induction of apoptosis by retinoids and retinoic acid receptor gamma-selective compounds in mouse thymocytes through a novel apoptosis pathway.

Szondy Z, Reichert U, Bernardon JM, Michel S, Tóth R, Ancian P, Ajzner E, Fesus L.

Mol Pharmacol. 1997 Jun;51(6):972-82.

PMID:
9187263
45.

Bcl-X(L) expression and its downregulation by a novel retinoid in breast carcinoma cells.

Hsu CK, Rishi AK, Li XS, Dawson MI, Reichert U, Shroot B, Fontana JA.

Exp Cell Res. 1997 Apr 10;232(1):17-24.

PMID:
9141616
46.

Expression and retinoid modulation of N-arginine dibasic convertase and an aminopeptidase-B in human neuroblastoma cell lines.

Draoui M, Bellincampi L, Hospital V, Cadel S, Foulon T, Prat A, Barré N, Reichert U, Melino G, Cohen P.

J Neurooncol. 1997 Jan;31(1-2):99-106.

PMID:
9049835
47.

Retinoic acid receptors beta and gamma distinguish retinoid signals for growth inhibition and neuritogenesis in human neuroblastoma cells.

Cheung B, Hocker JE, Smith SA, Reichert U, Norris MD, Haber M, Stewart BW, Marshall GM.

Biochem Biophys Res Commun. 1996 Dec 4;229(1):349-54.

PMID:
8954130
48.

Posttranscriptional regulation of p21WAF1/CIP1 expression in human breast carcinoma cells.

Li XS, Rishi AK, Shao ZM, Dawson MI, Jong L, Shroot B, Reichert U, Ordonez J, Fontana JA.

Cancer Res. 1996 Nov 1;56(21):5055-62.

49.

Regulation by retinoic acid of insulin-degrading enzyme and of a related endoprotease in human neuroblastoma cell lines.

Melino G, Draoui M, Bernardini S, Bellincampi L, Reichert U, Cohen P.

Cell Growth Differ. 1996 Jun;7(6):787-96.

Supplemental Content

Loading ...
Support Center